Nokayun secures angel round financing to set new benchmark for China's high-end scientific instruments

In March 2026, Nokayun announced the completion of its angel round financing. This financing round was led by Hongsheng Capital, with participation from Medistar Capital. The parties will work together to advance the research and development and industrialization of Chinese domestic high-end spectral flow cytometry technology, empowering fundamental life science research and the development of the precision medicine industry in China.

Nokayun is an innovative technology company focused on the independent research and development and production of high-end full-spectrum flow cytometers. Nokayun's core advantage lies in its proprietary, independently developed full-spectrum flow cytometry technology platform. Compared with traditional flow cytometry, full-spectrum flow cytometry uses an array detector to capture the complete and unique spectrum generated when fluorescent dyes are excited—referred to as the "fingerprint spectrum." By combining this with spectral unmixing algorithms, it overcomes the limitations of traditional flow cytometry, such as channel restrictions and severe fluorescence spillover, while also making instrument and software operation simpler and more intelligent. This results in a multicolor flow cytometry experience with higher sensitivity, better resolution, and greater flexibility in panel design.

Nokayun's Lymacyte S Full-Spectrum Flow Cytometer (488nm with 17 detection channels), leveraging innovative spectral acquisition and unmixing technology along with a stable sorting-grade micro-positive pressure dual-sheath fluid system, supports single-tube 12-color immunoprofiling. It balances ease of use with high performance, making full-spectrum technology accessible to more basic research scenarios and meeting the flow cytometry needs of small and medium-sized laboratories.

Lymacyte S Full-Spectrum Flow Cytometer

Nokayun's product line precisely addresses the diverse needs of users at different levels. In addition to the Lymacyte S single-laser platform, the Lymacyte multi-laser series full-spectrum flow cytometers can meet routine flow cytometry testing requirements while, leveraging advanced optical design and full-spectrum unmixing technology, achieving up to 50 fluorescence detection channels and supporting high-dimensional immunophenotyping of 30 colors or more per single tube. This provides a powerful tool for large-scale research platforms, drug discovery, and clinical translational research.

Furthermore, Nokayun offers flexible, customized solutions tailored to users' specific research needs, demonstrating strong underlying technical support and engineering implementation capabilities. Nokayun's products have been successfully installed and are operating reliably at top domestic universities and research institutions in China, including Tsinghua University and Nanjing Medical University. Their outstanding performance, stable operation, and professional technical support services have earned widespread recognition from early users.

Lymacyte Series Full-Spectrum Flow Cytometer